checkAd
    Startseite > Aktien > BioAtla > Nachrichten
    BioAtla Aktie
    2,8300
     
    USD
    -8,71 %
    -0,2700 USD
    Letzter Kurs 02:00:00 Nasdaq
    2,8300
     
    USD
    2.400 STK
    Geldkurs 17.05.24
    2,8400
     
    USD
    2.100 STK
    Briefkurs 17.05.24
    ISIN: US09077B1044 · WKN: A2QLBN · SYM: BCAB · USA

    Neueste Nachrichten

    BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress
    14.05.24 · globenewswire · BioAtla
    BioAtla to Participate in the Citizens JMP Life Sciences Conference
    08.05.24 · globenewswire · BioAtla
    BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024
    07.05.24 · globenewswire · BioAtla
    BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors
    06.05.24 · globenewswire · BioAtla
    BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    24.04.24 · globenewswire · BioAtla
    BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
    26.03.24 · globenewswire · BioAtla
    BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlights on March 26, 2024
    19.03.24 · globenewswire · BioAtla
    BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    07.03.24 · globenewswire · BioAtla
    BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
    20.12.23 · globenewswire · BioAtla
    BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
    30.11.23 · globenewswire · BioAtla
    BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
    28.11.23 · globenewswire · BioAtla
    BioAtla to Participate in the Jefferies London Healthcare Conference
    06.11.23 · globenewswire · BioAtla